Business Context and Reporting Period
This Form 8-K filing by CytoSorbents Corporation reports a corporate event dated April 1, 2016. The filing concerns the approval of a lease amendment for the Company's corporate headquarters and manufacturing facility located in Monmouth Junction, New Jersey.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial data provided relates to the specific lease terms:
- Facility Size: 12,400 square feet.
- New Monthly Rent: $23,950 per month, effective June 1, 2016.
Material Changes
The Board of Directors approved the Fourteenth Amendment to the Lease Agreement with Princeton Corporate Plaza, LLC. This amendment extends the lease term through May 31, 2017. Additionally, the amendment grants the Company an option to extend the lease for an additional year through May 31, 2018, subject to certain conditions.
Outlook, Risks, and Management Commentary
Management notes that the summary provided in this filing is not complete and is qualified by reference to the full text of the Lease Amendment. The full agreement is intended to be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2016. No specific risks or contingencies beyond the standard lease conditions were detailed in this text.
Investor Verification Points
- Verify the specific conditions required to exercise the option to extend the lease through May 31, 2018.
- Review the full Lease Amendment text in the upcoming Form 10-Q for the quarter ended March 31, 2016.
- Confirm the impact of the new rent obligation ($23,950/month) on the Company's operating expenses relative to prior periods.